Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Selective chemoembolization in the management of hepatic metastases in refractory colorectal carcinoma: a phase II trial.

Selective chemoembolization in the management of hepatic metastases in refractory colorectal carcinoma: a phase II trial. Dis Colon Rectum. 1997 Jul; 40(7):770-5.

View in: PubMed

© 2021 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.